Genome-Wide Association Study of Tacrolimus Pharmacokinetics Identifies Novel Single Nucleotide Polymorphisms in the Convalescence and Stabilization Periods of Post-transplant Liver Function
After liver transplantation, the liver function of a patient is gradually restored over a period of time that can be divided into a convalescence period (CP) and a stabilizing period (SP). The plasma concentration of tacrolimus, an immunosuppressant commonly used to prevent organ rejection, varies a...
Main Authors: | Yuan Liu, Chengdong Zhang, Lei Li, Baochi Ou, Liyun Yuan, Tao Zhang, Junwei Fan, Zhihai Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2019.00528/full |
Similar Items
-
The Impact of Single Nucleotide Polymorphisms on the Pharmacokinetics of Tacrolimus in Kidney Allograft Recipients of Northern-West, Iran
by: Elaheh Jabbari Hagh, et al.
Published: (2023-03-01) -
Genetic factors underlying tacrolimus intolerance after liver transplantation
by: Yuan Liu, et al.
Published: (2022-09-01) -
Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
by: Jefferson Antonio Buendía, et al.
Published: (2020-09-01) -
Tacrolimus—why pharmacokinetics matter in the clinic
by: Lino Henkel, et al.
Published: (2023-08-01) -
Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients
by: Yi Yi Htun, et al.
Published: (2020-03-01)